College of Science students Adam Chvilicek and Delaney Weiland spent the summer volunteering with the Boston Health Care for the Homeless Program as they prepare for future careers in health care.
Biological sciences major Eunice Agyapong has spent the past two summers conducting research in a Kumasi hospital on doctor-patient relations.
The new program featured 19 students from seven campuses — Saint Mary’s College, Indiana University South Bend, Indiana University Bloomington, Goshen College and Ball State University, in addition to Notre Dame and IUSM-SB.
Siyuan Zhang, the Dee Associate Professor of Biological Sciences who is also affiliated with the Harper Cancer Research Institute, landed a nearly $1.1 million Breast Cancer Research Program Breakthrough Award through the Department of Defense in August.
What role can Notre Dame play in the revolution building around rare disease research? A collaborative team of stakeholders discussed different options during a working session in October.
Researchers at the University of Notre Dame studying tumors in prostate cancer models found that nitration of an amino acid can inhibit T-cell activation, thwarting the T-cell’s ability to kill cancer cells.
From Saturday, October 28 through Thursday, November 1, members of the University of Notre Dame research community will travel to New Orleans, LA for the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting. Of the over 40 Notre Dame faculty, researchers, and students in attendance, many will be presenting their research through lectures, presentations, and posters.
Xin Lu, the John M. and Mary Jo Boler Assistant Professor of biology, was awarded a 2018 Susan G. Komen research grant to identify potential new therapies for treating metastatic breast cancer.
Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.
What role can Notre Dame play in the revolution building around rare disease research? A collaborative team of stakeholders discussed different options during a working session in October.
Researchers at the University of Notre Dame studying tumors in prostate cancer models found that nitration of an amino acid can inhibit T-cell activation, thwarting the T-cell’s ability to kill cancer cells.
Guido Camargo España, postdoctoral research associate of biological sciences, has received a Postdoctoral Training Award inTranslational Research from the Indiana Clinical and Translational Sciences Institute (CTSI).
The Walther Foundation has made a $3.5 million matching-fund gift that it hopes will inspire those with a similar passion to support novel, multidisciplinary approaches to cancer research.
The College of Engineering, College of Science, and Notre Dame Research are jointly celebrating the Alumni Association’s Annual Reunion with an event on Friday, June 1, 2018. The festivities will be held in the new McCourtney Hall and will feature fun STEM themed food, drinks, and participatory activities.
Andrew Grose, a native of Sheboygan, Wisconsin, has been named valedictorian and Harisa Spahić, a Granger native and Penn High School graduate is salutatorian.
The College of Science will be offering a 1.5-credit pass/fail course in the Fall semester called “Introduction to Personalism in Medicine: The Pathos Project.”
…
When senior science-business major Katie Beriont signed on to play Division I softball for the University of Notre Dame, she never thought her effort on the field would make an impact on the lives of cancer patients and their families. Now in her final season, Beriont has taken a role in organizing the team’s 8th annual Strikeout Cancer event.
Beta-lactam antibiotics, including penicillin, are one of the most widely used class of antibiotics in the world. Though they’ve been in use since the 1940s, scientists still don’t fully understand what happens when this class of drugs encounters bacteria. Now, researchers at the University of Notre Dame have elucidated how an enzyme helps bacteria rebound from damage inflicted by antibiotics not strong enough to immediately kill the bacteria on contact.
Tiny proteins found in the genomes of some types of bacteria are effective weapons against a wide range of other bacteria, opening the door for the development of new therapies in the age of antibiotic resistance, according to new research at the University of Notre Dame.
Every spring, St. Jude Children’s Research Hospital hosts the National Graduate Student Symposium (NGSS). The Symposium is held for the nation’s top Ph.D. students to present their work and learn more about St. Jude’s advanced research and facilities, which is located in Memphis, Tenn. This year, among more than 1500 applicants who had to be invited to apply, only 41 were selected. Notre Dame biology graduate student Mark Hawk is among this year’s attendees.
On the occasion of International Women's Day 2018, meet seven scholars whose work is inspiring others to #PressForProgress.
Kaitlin Cole, like many other sophomores in the College of Science, intends to go to medical school after graduation. She also has dreams of becoming an orthopedic surgeon. Unlike many other aspiring doctors, however, Cole has a rigorous athletics schedule — as a member of the Notre Dame women’s top-five NCAA basketball team.
For a team of Notre Dame psychologists, virtual reality is more than a game — it is the next frontier in mental health treatment. Nathan Rose, Jennifer Hames, and Michael Villano are conducting research on the use of virtual reality environments in exposure therapy for participants with a fear of heights. The technology also holds promise for treating phobias like the fear of flying and post-traumatic stress disorder.
Researchers at the University of Notre Dame discovered that the activation of a specific enzyme may help suppress the spread of tumors.
Faculty from the University of Notre Dame will present their research at the Walther Cancer Foundation Symposium on Friday, Feb. 2 to Saturday, Feb. 3, 2018. The two-day event is hosted by the Harper Cancer Research Institute (HCRI) and will take place at the Eck Visitors Center.
The Harper Cancer Research Institute (HCRI) has received a $300,000 Institutional Research Grant (IRG) from the American Cancer Society (ACS), which is a renewal of the IRG grant from 2014.
Our vision at the HCRI is to be a preeminent cancer research institute that effectively combines research, education and outreach to address the major challenges in cancer research, provide training opportunities for the next generation of oncology researchers, and to serve the greater good in the global community. It is by intentional design that the central pillar of our vision statement is the education of our trainees.
Sean Moore, a research assistant professor in the Department of Biological Sciences and the Eck Institute for Global Health, has coauthored a paper mapping the incidence of cholera in Africa, a critical step in the World Health Organization’s goal of reducing cholera deaths by 90 percent over the next decade.
Enlighten Mobility, founded by ESTEEM student Marissa Koscielski, is a medical device company that is a catalyst for patient empowerment through rehabilitation.
Faculty from the University of Notre Dame will present their research at the Walther Cancer Foundation Symposium on Friday, Feb. 2 to Saturday, Feb. 3, 2018. The two-day event is hosted by the Harper Cancer Research Institute (HCRI) and will take place at the Eck Visitors Center.
